Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Aspirin in CABG
NCT02942680Phase 3Unknown
- Sponsor
- E. Meshalkin National Medical Research Centre
- Start
- Jan 2016
- Primary completion
- Jan 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin in coronary heart disease (CHD), sponsored by E. Meshalkin National Medical Research Centre. Status: unknown.
02
Drugs
aspirin
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT02942680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02942680.